Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Moffat’s solution versus adrenaline nasal preparation in endoscopic sinus surgery
ACTRN12617000303347Phase 4Recruiting
- Sponsor
- Dean Page
- Start
- Jan 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cocaine and epinephrine in rhinosinusitis (2 arms), sponsored by Dean Page. Primary endpoint: Systemic cocaine absorption after intranasal atomised modified Moffat’s solution. Started Jan 2017; status: recruiting.
02
Drugs
cocaineepinephrine
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on ACTRN12617000303347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000303347.